But with GLP-1 sales vanishing, Hims is left banking on generic weight-loss pills and its core business in hair-loss and ED treatments. While that business is solid, it doesn't justify the lofty ...

Hims & Hers (HIMS ... Yemi Okupe revealed a major shift. Future weight-loss offerings will be “primarily composed” of generic weight-loss pills and an older GLP-1 drug called liraglutide.

Hims & Hers (HIMS), the millennial-skewed telehealth company, saw its stock tumble nearly 9% on Tuesday, as the company braces for big regulatory shifts in the weight-loss drug industry.

Telehealth company Hims & Hers Health (HIMS ... triggering mixed reviews from analysts about the future of its weight loss business. See what stocks are receiving Strong Buy ratings from top ...

Hims & Hers is set to continue offering weight-loss pills and personalized weight-loss support, including nutrition plans and coaching. Outside of weight-loss care, the company saw its subscriber ...

Hims offers several products to help prevent and treat hair loss. Some are only available with a prescription. We break these products down for you in our review ... take one pill a day—but ...

But with GLP-1 sales vanishing, Hims is left banking on generic weight-loss pills and its core business in hair-loss and ED treatments. While that business is solid, it doesn't justify the lofty ...

Hims & Hers has risen since November 2024, outperforming the S&P 500. Click here to see why HIMS stock is a Buy.

Hims & Hers Health is a top growth stock with strong cash flow, no debt, and an innovative AI-powered platform. Learn more on ...

with services spanning from skin care and hair loss to anxiety and erectile dysfunction. This review examines its erectile dysfunction (ED) services, looking closely at what Hims offers its users ...

Hims also launched an oral weight-loss regimen in late 2023. These pills combine bupropion, metformin, topiramate, vitamin B12, and naltrexone. Three of the four are treatments for other diseases ...

On the call, Okupe said Hims’ “steady state weight-loss offering” would be “primarily composed” of generic weight loss pills—not GLP-1 medicines—along with a generic version of an ...